MONTREAL, Sept. 4, 2025 /PRNewswire/ -- Congruence, a computationally-driven biotechnology company building a unique pipeline of pharmacological correctors for diseases of protein misfolding, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback